News
EQS-Adhoc: STRATEC POSTS PRELIMINARY RESULTS FOR FIRST HALF AND ADJUSTS GUIDANCE FOR 2023 FINANCIAL YEAR
Should You Buy This Dividend-Growth Machine for Your Portfolio?
For a dividend-growth investor, the path to lasting success is as simple as buying and holding businesses that are consistently growing. After all, steadily rising profits drive dividend growth over
Should You Buy This Dividend-Growth Machine for Your Portfolio?
For a dividend-growth investor, the path to lasting success is as simple as buying and holding businesses that are consistently growing. After all, steadily rising profits drive dividend growth over
The Retirement Mistake That Costs 4 in 10 People Thousands of Dollars
Employer-sponsored retirement plans like the 401(k) are the primary tool working people use to save for their golden years. People used to spend all or most of their working years with one company
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
1 Green Flag and 1 Red Flag For Medtronic
You may have come into close contact with Medtronic (NYSE: MDT) if you've undergone a medical procedure. The company makes devices used in endoscopy, spine surgery, cardiovascular diagnostics -- and
Should You Buy the Dip With Biogen Stock Right Now?
With shares of Biogen (NASDAQ: BIIB) falling by 11% in the last 30 days, and by 20% in the last five years, could there be an opportunity for enterprising investors to buy the dip on this struggling
Should You Buy the Dip With Biogen Stock Right Now?
With shares of Biogen (NASDAQ: BIIB) falling by 11% in the last 30 days, and by 20% in the last five years, could there be an opportunity for enterprising investors to buy the dip on this struggling
Should You Buy the Dip With Biogen Stock Right Now?
With shares of Biogen (NASDAQ: BIIB) falling by 11% in the last 30 days, and by 20% in the last five years, could there be an opportunity for enterprising investors to buy the dip on this struggling
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
2 Monster Stocks to Buy Without Any Hesitation
Everyone's portfolio should include a couple of monster stocks. What do I mean by "monster"? I'm talking about companies that have a solid earnings track record and offer bright prospects down the
2 Monster Stocks to Buy Without Any Hesitation
Everyone's portfolio should include a couple of monster stocks. What do I mean by "monster"? I'm talking about companies that have a solid earnings track record and offer bright prospects down the
2 Monster Stocks to Buy Without Any Hesitation
Everyone's portfolio should include a couple of monster stocks. What do I mean by "monster"? I'm talking about companies that have a solid earnings track record and offer bright prospects down the
These 2 Numbers Should Scare Every Biogen Shareholder
Most Biogen (NASDAQ: BIIB) shareholders are probably excited about the company's newly approved Alzheimer's drug Leqembi right about now, and it's no surprise why. Some commentators are calling for
These 2 Numbers Should Scare Every Biogen Shareholder
Most Biogen (NASDAQ: BIIB) shareholders are probably excited about the company's newly approved Alzheimer's drug Leqembi right about now, and it's no surprise why. Some commentators are calling for
These 2 Numbers Should Scare Every Biogen Shareholder
Most Biogen (NASDAQ: BIIB) shareholders are probably excited about the company's newly approved Alzheimer's drug Leqembi right about now, and it's no surprise why. Some commentators are calling for
3 Dividend Growth Stocks to Buy and Hold
Wayne Gretzky probably had no idea how much one thing he said would be repeated through the years. But one of his most famous statements certainly was memorable and worthy of repetition: "I skate to
3 Dividend Growth Stocks to Buy and Hold
Wayne Gretzky probably had no idea how much one thing he said would be repeated through the years. But one of his most famous statements certainly was memorable and worthy of repetition: "I skate to
7 Spectacular High-Yield Dividend Stocks to Buy in July
You don't have to settle for puny dividend income. Thousands of stocks offer dividends. Many of them, though, have dividend yields that don't amount to a hill of beans.
What if you could invest in
Better High-Yield Dividend Stock: Altria or Viatris?
If you are looking for a high-yield dividend stock to boost your income, you might be interested in Altria (NYSE: MO) or Viatris (NASDAQ: VTRS). Both companies offer attractive dividend yields of
Better High-Yield Dividend Stock: Altria or Viatris?
If you are looking for a high-yield dividend stock to boost your income, you might be interested in Altria (NYSE: MO) or Viatris (NASDAQ: VTRS). Both companies offer attractive dividend yields of
Why Shares of Fresenius Medical Jumped This Week
Shares of Fresenius Medical Care (NYSE: FMS) were up more than 11% for the week as of Friday at 1:30 p.m. ET, according to data provided by S&P Global Market Intelligence. The German healthcare
UnitedHealth Group (UNH) Q2 2023 Earnings Call Transcript
UnitedHealth Group (NYSE: UNH)Q2 2023 Earnings CallJul 14, 2023, 8:45 a.m. ET
Operator
Source Fool.com
UnitedHealth Group (UNH) Q2 2023 Earnings Call Transcript
UnitedHealth Group (NYSE: UNH)Q2 2023 Earnings CallJul 14, 2023, 8:45 a.m. ET
Operator
Source Fool.com
Why Shares of UnitedHealth Group Are Up Friday
Shares of UnitedHealth Group (NYSE: UNH), the nation's largest private medical insurer, were up more than 6.6% as of 11 a.m. ET on Friday after the company reported second-quarter earnings. The heal